Article
Protease inhibitor resistance update: where are we now?
AIDS patient care and STDs - 1 Apr 2008
Kim Rose, Baxter John D
Abstract excerpt
The introduction of protease inhibitors (PIs) and highly active antiretroviral therapy in the mid-1990s dramatically altered the treatment of HIV infection, enabling suppression of viral replication to undetectable levels and preventing disease progression. Most PIs present a strong barrier against viral resistance; the accumulation of multiple mutations is often required to produce resistance. However, there is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
